Copanlisib and Gemcitabine in Relapsed/Refractory PTCL

Clinical trial NCT03052933 · COMPLETED

Trial details

NCT number: NCT03052933
Sponsor: Chonnam National University Hospital
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Mature T-Cell and NK-Cell Neoplasm

Start date: 2018-02-01
Primary completion: 2021-07-01
Enrollment: 28

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.